n-isopropyl-4-formylbenzamide has been researched along with procarbazine in 1 studies
*Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. [MeSH]
*Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maki, PA; Sladek, NE | 1 |
1 other study(ies) available for n-isopropyl-4-formylbenzamide and procarbazine
| Article | Year |
|---|---|
Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
Topics: Aldehyde Dehydrogenase; Animals; Antineoplastic Agents; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Drug Synergism; Hematopoietic Stem Cells; Inactivation, Metabolic; Kinetics; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred BALB C; Phosphoramide Mustards; Procarbazine | 1991 |